NeuralCipher Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
Abstract Background: Pancharavinda Choornam is an Ashtavaidya formulation traditionally recognized for its Medhya (cognitive enhancing) properties and is used in the management of neuropsychiatric comorbidities such as insomnia, anxiety, and depression associated with neurodegenerative disorders. Aim of the study: This study aimed to elucidate the mechanism of action of Pancharavinda Choornam in cognitive enhancement and comorbidity management in neurodegenerative conditions using a network pharmacology approach. Materials and methods: In vitro antioxidant assays were performed to assess antioxidant potential, followed by network pharmacology analysis to identify compound–target interactions and multitarget pathway modulation. Results: The formulation demonstrated significant antioxidant activity and modulated key genes, including APP (amyloid precursor protein), TAU (microtubule associated protein tau), MAOA (monoamine oxidase A ), BACE (beta site amyloid precursor protein–cleaving enzyme 1), PSEN (presenilin), and PSEN1 (presenilin 1) involved in neurodegenerative pathways. Conclusion: Pancharavinda Choornam exhibits multitarget therapeutic potential and may serve as a promising candidate for the management of Alzheimers and Parkinsons diseases.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.